Researchers Study: No Apnea / Cancer Link

Dental Sleep Apnea Appliances Have Advantages Over Traditional Solutions, Woodland Hills Dental Expert Says A study by Canadian researchers released earlier this month found no evidence linking obstructive sleep apnea with cancer. As this report is likely to increase public awareness and discussion of sleep apnea, prosthodontist Dr. Saj Jivraj of the Anacapa Dental Art Institute in Ventura County, Calif., is urging members of the media and the public to look beyond surgery and Continuous Positive Airway Pressure (CPAP) as the only remedies for sleep apnea. Woodland Hills, CA – August 26 – A study by Canadian researchers released Aug. 5 in the Canadian Medical Association Journal found no evidence linking obstructive sleep apnea with cancer. As this report is likely to increase public awareness and discussion of sleep apnea, prosthodontist Dr. Saj Jivraj of the Anacapa Dental Art Institute in Ventura County, Calif., is urging members of the media and the pub lic to look beyond surgery and Continuous Positive Airway Pressure (CPAP) as the only remedies for sleep apnea. There is a common, non-surgical solution that highly trained dentists use to treat the condition â?? Oral Appliance Therapy. CPAP still is considered the â??standard” treatment by many physicians, but with usage rates reportedly less than 50 percent, many patients would be better served using a proven, alternative therapy, Dr. Jivraj said. â??The Academy of Sleep Medicine (AASM) guidelines say that patients with mild or moderate sleep apnea should be given a choice between a CPAP machine or an oral appliance,â? Dr. Jivraj said. â??Patients deserve to be told of all their sleep apnea treatment options, including Oral Appliance Therapy.â? While many people associate Dr. Jivraj and his partner, Dr. Mamaly Reshad, with their Woodland Hills cosmetic dentistry services, the Anacapa Dental Art Institute can provide patients with an oral appliance to address their sle ep apnea. The oral appliance created to treat sleep apnea usually consists of custom-made, removable upper and lower trays that fit over the patientâ??s teeth. A mechanism connects the upper and lower trays and holds the wearersâ?? jaw forward while he or she sleeps. By holding the jaw forward, the oral appliance moves the tongue forward and keeps it from blocking the airway during sleep, which is what occurs in sleep apnea. Prosthodontists like Dr. Jivraj and Dr. Reshad have advanced dental training about oral health conditions, including sleep apnea, and specialize in fitting and finding the correct position to treat mild to moderate cases of sleep apnea without surgery or CPAP. Dr. Jivraj and Dr. Reshad are award-winning prosthodontists. They are specialists in implant, cosmetic and reconstructive dentistry. Both are former chairmen of the University of Southern California School of Dentistryâ??s Fixed Prosthodontics and Operative Dentistry section. They also are intern ational lecturers and published authors. Dr. Jivraj earned his degree at the University of Manchester in his native England. He received advanced prosthodontic training at the USC School of Dentistry. He has published numerous articles on aesthetic and implant dentistry in peer-reviewed journals, and has presented on implant dentistry and advanced prosthodontic procedures nationally and internationally. Dr. Jivraj is co-author of the textbook â??Treatment Planning in Implant Dentistry,â? which is used around the world. He is on the editorial board of the highly prestigious Journal of Esthetic and Restorative Dentistry, ad hoc reviewer for the Journal of Prosthetic Dentistry and is associate clinical editor for Dental Teamwork magazine. He currently holds a faculty position as an associate clinical professor at the USC School of Dentistry, clinical teacher at the Eastman Dental Institute in London and is on the board of directors for the British Academy of Restorative Den tistry. Jivraj was voted â??Best of USAâ? by his peers in 2008. Dr. Reshad, a fellow prosthodontist, is an internationally known expert in restorative and cosmetic dental procedures. He has published in numerous peer-reviewed journals and textbooks on various topics related to prosthodontics, aesthetics and implant dentistry. Dr. Reshad trained at Kings College Dental School followed by the Eastman Dental Institute in London. Dr. Reshad is on the editorial board for the Journal of Esthetic and Restorative Dentistry. He is an honorary clinical teacher at the Eastman Dental Institute and a member of the faculty of the Global Institute for Dental Education. The Anacapa Dental Art Institute has been offering quality dental care treatments since 1996. The team specializes in implant, prosthodontic, cosmetic and restorative dentistry. It also offers gentle dental care treatments for patients aged 50 and above. The Anacapa Dental Art Institute has two new sta te-of-the-art training and dental offices in Oxnard and Woodland Hills, Calif., respectively. The Oxnard location, at 2821 North Ventura Road, Bldg H, has 3,600 square feet encompassing six treatment rooms, a fully in-house dental lab and a state-of-the-art teaching center, according to Anacapa Dental Art Institute founder Dr. Saj Jivraj. The on-site teaching center includes a high-tech suite where other dentists can observe patient treatments. Courses have been arranged for dentists from Japan, China, India and South America. The Woodland Hills office, at 6325 Topanga Canyon Boulevard, No. 513, is 1,500 square feet and it features an in-house dental lab catering to patients in and around Los Angeles. The Anacapa Dental Art Institute has a staff of 11, which includes the two prosthodontists, a root canal specialist, a general dentist, two hygienists, three dental assistants and two receptionists. The Anacapa Dental Art Institute provides the following procedures: ? All-on -4 dental implants ? All on Six (All on 6) dental implants ? Mini dental implants ? New smile in a day ? Teeth in an Hour ? Full mouth reconstruction ? Teeth whitening ? Invisalign teeth straightening ? Sedation dentistry ? Cosmetic dentures (â??faceliftâ?) Those looking for a Thousand Oaks dentist or Ventura affordable cosmetic dentistry can get more information about Dr. Jivraj and Dr. Reshad at Dentalimplantsventura.com or call the Oxnard office at (805) 604-5811 or the Woodland Hills office at (818) 839-7419. Contact Information Saj Jivraj Anacapa Dental Art Institute http://www.DentalImplantsVentura.com +1 (805) 604-5811

Posted in Mesothelioma News | Leave a comment

Compound Sensitizes Mesothelioma Cells

New Research Finds Compound Sensitizes Mesothelioma Cells to Tumor-Fighting Drugs, According to Surviving Mesothelioma Italian researchers say a treatment made from a human protein can help improve the effectiveness of chemotherapy for patients fighting malignant pleural mesothelioma. Raleigh, NC – June 20 – A team of cancer doctors says the combination of a lab-created compound based on a human protein and traditional chemotherapy drugs can help shrink mesothelioma tumors better than either treatment alone. Surviving Mesothelioma has just posted an article on the new research. Doctors with the University of Padua and the Instituto Oncologico Veneto in Padua have found that a version of TNL-related apoptosis-inducing ligand (TRAIL), a protein produced by healthy tissues, can trigger the destruction of mesothelioma cells when combined with carboplatin and pemetrexed (CP). Researchers referred to the TRAIL compound as â??Tâ??. â??Results demonstrated a sign ificant increase of apoptosis in cell lines treated with CPT compared with those receiving CP or T as single agents,â? reports medical oncologist, Guilia Pasello, MD, the studyâ??s primary author. In their new report in the Journal of Thoracic Oncology, the researchers hypothesize that the chemotherapy drugs may make mesothelioma cells more sensitive to TRAILâ??s cell death signals. The cell-destroying effect of the CPT combination worked on mesothelioma cells lines in the lab, as well as in live mice. â??Although most mesothelioma patientswill have chemotherapy at some point during treatment, it has only limited effectiveness,â? says Surviving Mesotheliomaâ??s Managing Editor, Alex Strauss. â??If another compound could help these drugs work better, it could potentially improve outcomes for thousands of mesothelioma patients every year.â? For a more complete explanation of how the CPT combination is thought to work, see Combination Treatment Fights Mesothelioma â??Syne rgisticallyâ?, now available on the Surviving Mesothelioma website. Source: Pasello, G. et al., â??Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma.” For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis, and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions. Contact Information Michael Ellis Cancer Monthly http://www.survivingmesothelioma.com +1 (919) 570-8595

Posted in Mesothelioma News | Leave a comment

County to Remove Asbestos

County to Remove Asbestos from the Mexico DSS Building

Pulaski â?? Oswego County has decided to hire Tetra Tech Architects & Engineers for an asbestos abatement project. Asbestos-containing tiles at the Mexico DSS (Department of Social Service) building will be removed. The decision was approved by the legislators on Thursday. They have also increased the capital funding for the asbestos abatement project from US$30000 to 100000.
The initial asbestos survey and the agreement with the abatement contractor will be covered by the US$100,000. The cancer-causing mineral was originally found in the Mexico DSS building in early 2012, after a staff member asked Oswego County whether they had ever tested the tiles.
The levels of asbestos are somewhat higher than the federally accepted levels, said Phil Church, the administrator. Air sampling tests indicated that t he region was absolutely safe for working. However, each time the tiles were shifted for accessing cables, telephone cables, and environmental management systems, the risk of asbestos fibers to become airborne increased. When it becomes airborne, asbestos can be dangerous. Whoever inhale those tiny fibers are at risk of developing fatal asbestos-related diseases including lung cancer, asbestosis and mesothelioma. Asbestos is not so dangerous as long as it remains stable. Release of asbestos fibers into the air and subsequent dangers occur only when the material is broken or disturbed.
Congressmen will finally say regarding the amount spent on the asbestos abatement. However, alterations inside the structure can also be a part of the abatement project. Officials said on Thursday that the county will be reimbursed 75% of the abatement expenses by the state.
Though the county has taken a decision on asbestos abateme nt project, it has many other decisions that are still pending. Tetra Tech will invite bids for sub-contracting. The bids are supposed to reach in September.
The complete expense of the asbestos abatement will be known only after seeing the bids. However, Church guesses the expense could be between $600,000 and $800,000.
Because of worries that the asbestos removal and remodeling could cost $1 million, Congressperson Louella LeClair voted against the decrees in a meeting of the Finance & Personal and the Infrastructure & Facilities committees. However, later she supported the resolution once it has been explained that the legislators will have the last say.
â??I feel it is really important that the asbestos is removed. No doubt, that must be done. The other issues should be watched more closely,â? Louella LeClair said.

Posted in Mesothelioma News | Leave a comment

Asbestos Lawsuit Names Companies

Charleston â?? A Melbourne (FL) couple has filed a lawsuit against 39 corporations that are allegedly liable for a mesothelioma diagnosis. The lawsuit was filed by Barbara Amick and her husband Eldon Amick in Kanawha Circuit Court on April 20. The suit says Barbara Amick was diagnosed with mesothelioma on December 13, 2011. The plaintiffs say the defendant companies are responsible for the mesothelioma diagnosis as they exposed Barbara Amick to asbestos which is why she developed the malignant disease. Barbara Amick was employed in sales and accounts departments from 1952 to 1977, the complaint says. Barbara Amick says she was also exposed to the cancer-causing material during renovations at her husbandâ??s Vienna home between 1950 and 1970. The plaintiffs are asking for punitive and compensatory damages.

Posted in Mesothelioma News | Leave a comment

Students Relocated Because of Asbestos

Hale Rd. Elementary School Students to be Relocated Because of Asbestos Students of Hale Rd. Elementary School in the Painesville Township may possibly be relocated for one month or more for the beginning of school year. Asbestos material was disturbed while construction work was ongoing at the elementary. The process of cleanup would take at least a month to finish. James Kalis, the Superintendent of Riverside Schools, will visit the building, which is the probable candidate for the kindergarten through 3rd-grade students. The students who would be relocated may take their classes at the Painesville Assembly of God (PAG), Concord Township. In the meantime, 4th and 5th graders are going to vacate classrooms at LaMuth School, Concord Township. The space will be leased by the school district from the PAG church. The price for this has not bee decided so far, according to Kalis. â??< strong>The church also is actually working with the school. They are keen to help us,â? Kalis said. He said that the PAG church was not looking to make profit out of the lease. The department of fire will check the church building to make sure that it is adequate for teaching. However, Kalis said, he was optimistic that the building would be safe and suitable. â??It is a provisional, but adequate location,â? Kalis said. The school district is also planning to hold one open house. It could be used for parents to visit the buildings before their children. The school will also provide transportation for all those who resides outside of 1-mile radius of the buildings. The school was about to complete a $3 M project, which included replacement of roof and a latest Heating Ventilation & Air Conditioning (HVAC) system. Though asbestos has been banned from using as building material, the material is still a major problem for many schools in the United States. The problem is that those buildings were constructed at a time when asbestos was an extensively used construction material. As it can cause severe respiratory problems and terminal diseases such as cancer if its fibers are breathed in, removal of asbestos should be done with extreme care. Only licensed asbestos contractors are allowed to handle the substance. Asbestos removal is a time-consuming as well as expensive process. There are strict regulations to be followed when an asbestos abatement project is being carried out. Violations of these regulations could result in potential fines and imprisonment.

Posted in Mesothelioma News | Leave a comment

Biotech Company Develops Cancer Vaccines

CIT GAP Funds Invests in PhosImmune Biotech Company Develops High-Quality Tumor Antigens for Cancer Vaccines Herndon, VA – August 12 – The Center for Innovative Technology (CIT) announced today that it closed an investment in PhosImmune, a Charlottesville-based clinical-stage biotechnology company developing therapeutic cancer vaccines. PhosImmune controls a library of unique, aberrantly phosphorylated tumor antigens (PTAs) that are directly implicated in metastasis, meeting a pressing need for high quality tumor antigens for use in new and more effective cancer vaccines. PhosImmuneâ??s PTAs are superior to conventional tumor antigens because they are derived from proteins associated with the process that drives cancer, and they target multiple forms of cancer, including leukemia, melanoma, and breast cancer. The Companyâ??s lead candidate, PxM-01, is currently in Phase I testing to treat melanoma. This technology stemmed from research at the University of Virginia. CIT P resident and CEO Pete Jobse said, â??The team at PhosImmune has developed PTAs that meet an important need in cancer treatment and will enable a variety of targeted immunotherapy approaches. Innovative solutions like this one are what we look for in making CIT GAP Funds investments.â? PhosImmune President Donald Hunt said, â??We will use the investment from CIT GAP Funds to expand and continue our current trials, and to develop an additional PTA-based immunotherapy.â? CIT GAP Funds is a family of seed- and early-stage investment funds placing near-equity and equity investments in Virginia-based high-growth technology, life science and clean technology companies. Tom Weithman, CIT Vice President and GAP Funds Managing Director, said, â??Companies with important and innovative solutions like PhosImmune often find it difficult to obtain the early-stage funding they need to continue to grow and develop their products. CIT GAP Funds looks to plug this funding gap, creating o pportunities for Virginia-based startups that can contribute significantly to the Commonwealthâ??s innovation economy.â? Since its 2005 launch, CIT GAP Funds has invested in over 100 companies across the Commonwealth of Virginia, deploying more than $13 million of public funds and attracting over $200 million more in private funding. About the Center for Innovative Technology, http://www.cit.org Since 1985, CIT, a nonprofit corporation, has been Virginiaâ??s primary driver of innovation and entrepreneurship. CIT accelerates the next generation of technology and technology companies through commercialization, capital formation, market development and revenue generation services. To facilitate national innovation leadership and accelerate the rate of technology adoption, CIT creates partnerships between innovative technology start-up companies and advanced technology consumers. CITâ??s CAGE Code is 1UP71. To learn more, ple ase visit http://www.cit.org. Follow CIT on Twitter @CITorg and add the Center for Innovative Technology on LinkedIn and Facebook. About the CIT GAP Funds, http://www.citgapfunds.org CIT GAP Funds makes seed-stage equity investments in Virginia-based technology, clean tech and life science companies with a high potential for achieving rapid growth and generating significant economic return for entrepreneurs, co-investors and the Commonwealth of Virginia. CIT GAP Funds investments are overseen by the CIT GAP Funds Investment Advisory Board (IAB). This independent, third-party panel consists of leading regional entrepreneurs, angel and strategic investors, and venture capital firms such as: New Enterprise Associates, Grotech Ventures, Valhalla Partners, Harbert Venture Partners HIG Ventures, Edison Ventures, In-Q-Tel, Intersouth Partners, SJF Ventures, Carilion Clinic, Johnson & Johnson, General Electric and Alpha Natural Resources. Contact Information Hap Connors Center for Innovative Technology http://www.cit.org +1 (703) 689-3048

Posted in Mesothelioma News | Leave a comment

Mesothelioma Biomarker Best for Diagnosis

Australian Team Says Gold Standard Biomarker Still Best for Mesothelioma Diagnosis, According to Surviving Mesothelioma Researchers comparing the mesothelioma biomarkers mesothelin and fibulin-3 say mesothelin is still the most effective marker for diagnosis but fibulin-3 has another use. Raleigh, NC – August 07 -  Scientists in Australia have just released the results of an important report comparing the relative values of the protein biomarkers mesothelin and fibulin-3 in the management of malignant pleural mesothelioma. Surviving Mesothelioma has just posted a new article on the study. Click here to read it now. The National Centre for Asbestos Related Diseases at the University of Western Australia studied the gold standard biomarker mesothelin and the newly-proposed marker fibulin-3 in 82 mesothelioma patients.. â??Soluble mesothelin is a superior diagnostic biomarker for malignant mesotheliomacompared with fibulin-3, whereas fibulin-3 provides supe rior prognostic information compared with mesothelin,â? writes lead author Jenette Creaney, PhD, a Professor at the University of Western Australia. The study published in the journal Thorax included a total of 153 patients â?? 82 with mesothelioma, 36 with malignant effusions (lung fluid buildup) from other types of cancers, and 35 with benign effusions. â??Clinicians need both diagnostic and prognostic information to effectively manage pleural mesothelioma,â? says Alex Strauss, Managing Editor of Surviving Mesothelioma. â??This study suggests that mesothelin and fibulin-3 both have important roles to play.â? For all the details on the study, see Mesothelioma Management: Different Biomarkers Serve Different Functions, now available on the Surviving Mesothelioma website. Creaney, J, â??Comparison of fibulin-3 and mesothelin as markers in malignant mesotheliomaâ?, July 18, 2014, Thorax, Epub ahead of print, http://thorax.bmj.com/content/early/2014/07/18/thoraxjnl-2014-205205.full.pdf. For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions. Contact Information Michael Ellis Cancer Monthy http://www.survivingmesothelioma.com +1 (919) 570-8595

Posted in Mesothelioma News | Leave a comment

Book Follows Couple Through Cancer Diagnosis

Randy Coatesâ??s New Book Follows Couple Through Mexico, Cancer Diagnosis “The Monarchs” displays old fashioned love, love of culture, travel, and nature. TORONTO – August 07 -  Author Randy Coates draws on real events from his life in his new book â??The Monarchsâ? (published by iUniverse). He combines a love of travel with the experiences of a friend to craft an engrossing, empathetic tale. In â??The Monarchs,â? two retired school teachers who travel to Mexico regularly are mesmerized by the annual migration of the monarch butterflies, which brings them spiritual comfort. The couple finds that Mexico is a soothing remedy while the husband battles prostate cancer. An excerpt from â??The Monarchsâ?: â??â??Itâ??s cancer,â?? he said and when she did not speak, he shrugged his shoulders and raised his hands. No one said anything for a moment. â??No.â?? He shrugged his shoulders again. â??Prostate, of course.â?? â??Oh Robertâ?¦â?? If not for the bad news , the sound of the swishing water as he adjusted himself would have been transfixing. It only added satire to the situation.â? â??Not many books that I have read show the physical love between two 60-year-olds, including their love-making,â? Coates says. â??The book shows that sexual relationships between two people, regardless of age, should not make anyone squirm.â? â??The Monarchsâ? By Randy Coates Hardcover | 5.5 x 8.5 in | 224 pages | ISBN 9781491708583 Softcover | 5.5 x 8.5 in | 224 pages | ISBN 9781491708590 E-Book | 224 pages | ISBN 9781491708576 Available at Amazonand Barnes & Noble About the Author Randy Coates graduated from the University of Waterloo with a bachelorâ??s degree and attained his teaching certificate from the University of Western Ontario. He works as a supply teacher for the Toronto District School Board. He has also published a childrenâ??s fantasy novel, â??More Precious Than Rubies: The Return of the Norse Gods.â? Mo re information is available at http://www.randycoates.com. iUniverse, an Author Solutions, LLC, self-publishing imprint, is the leading book marketing, editorial services, and supported self-publishing provider. iUniverse has a strategic alliance with Indigo Books & Music, Inc. in Canada, and titles accepted into the iUniverse Rising Star program are featured in a special collection on BarnesandNoble.com. iUniverse recognizes excellence in book publishing through the Star, Readerâ??s Choice, Rising Star and Editorâ??s Choice designationsâ??self-publishingâ??s only such awards program. Headquartered in Bloomington, Indiana, iUniverse also operates offices in Indianapolis. For more information or to publish a book, please visit iuniverse.com or call 1-800-AUTHORS. For the latest, follow @iuniversebooks on Twitter. Contact Information Marketing Services iUniverse +1 800-288-4677

Posted in Mesothelioma News | Leave a comment

Anticancer Drug Research Awarded

PolyU Scholar Received Award for Anti-Cancer Drug Research Dr. Tao Ye, Associate Professor of The Hong Kong Polytechnic University (PolyU)â??s Department of Applied Biology and Chemical Technology was recently awarded the 2014 Xiaoyu Hu Memorial Award at the 13th Chinese International Peptide Symposium (CPS) held in Datong, China, from 30 June â?? 4 July 2014. The award was presented to Dr. Ye in recognition of his outstanding achievements in the peptide science field, contributing to the research in synthesis of natural products and exploration of natural-products-based anti-cancer drugs. Hong Kong -  August 08 -  Dr. Tao Ye’s research resulted in the discovery of novel anti-cancer agents based on marine natural products largazole, burkholdacs and computational-aided drug design. These anticancer agents have been proven effective in controlling cancer proliferation via inhibition of histone deacetylases and histone demethylases. The CPS was founded in 1990 by w orld leading scholars in the peptide field, including Nobel Laureate Bruce Merrifield. It is one of the most important events in the field of peptide science, on par with the American Peptide Symposium, European Peptide Symposium and Japanese Peptide Symposium etc. The Xiaoyu Hu Memorial Award was established by the CPS in commemoration of Professor Xiaoyu Hu, a pioneer and leader in the development peptide science in the Chinese mainland. The award honors biennially one Chinese and one international scientist with outstanding contribution in the peptide science field. The other winner of the 2014 Xiaoyu Hu Memorial Award was Professor Paul Alewood, Chairman of Australian Peptide Association. Anticancer Drug As a leading scientist in the field of synthetic chemistry and chemical biology, Dr Yeâ??s research focuses on the total synthesis of biological active natural products and chemical proteomics. His laboratory is particularly devoted to the research in synthesis and biological evaluation of natural products, especially in the exploration of natural-products-based novel anti-tumor agents. Dr Tao Ye also received the WuXi PharmaTech Life Science and Chemistry Award in 2012. His anti-cancer drug discovery program was supported by generous donation from both Fong Shu Fook Tong Foundation and Joyce M. Kuok Foundation. Press contact Dr Tao Ye, Associate Professor Department of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Email: tao.ye(at)polyu.edu.hk Contact Information Ms Agnes Kwan The Hong Kong Polytechnic University http://www.polyu.edu.hk +852 2766 6374

Posted in Mesothelioma News | Leave a comment

Cancer Diagnostics Discussed

Cancer Diagnostics Universe Discussed in Comprehensive VPG Research Study Published at MarketPublishers.com Comprehensive study â??2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains–Hospitals, Commercial Labs, POC Locationsâ? prepared by Venture Planning Group (VPG) is now available at MarketPublishers.com. London, UK (PRWEB) August 06, 2014 The market for cancer diagnostics is on the verge of exploding, as the research workers approach key technology advances relating to tumour diagnosis and treatment, discover novel tumour-specific antigens, and also get to the heart of the mystery of the genetic basis of this insidious disease. Over the next five years, the global cancer diagnostics marketplace promises to be a very dynamic and rapidly expanding sphere. Expected advancements in technology will create multiple opportunities for determi ning genetic susceptibility, identifying specific tumours, and investigating the human body’s biological response to cancer therapy and treatment. Furthermore, the upsurge in the ageing human population is anticipated to compound the soaring demand for malignancy assays and the fast-paced market expansion from pole to pole. Comprehensive study â??2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains–Hospitals, Commercial Labs, POC Locationsâ? prepared by Venture Planning Group (VPG) is now available at MarketPublishers.com. Report Details: Title: 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains–Hospitals, Commercial Labs, POC Locations Published: July, 2014 Pages: 1200 Price: US$ 34,500.00 http://marketpublishers.com/report/diagnostics-diseases/cancer/2014-market-segmentation-analysis-of-global-cancer-diagnostics-industry.html The research report provides a strategic analysis of key business opportunities in the cancer diagnostics market globally with a focus on the 7 key countries (France, Germany, Italy, Japan, Spain, the UK, and the USA) in the forthcoming years. The report examines trends in the regions covered; reviews current and emerging assays; analyses potential applications of innovative diagnostic technologies; covers sales and market shares of leading suppliers of cancer diagnostic products (by test and country); presents sales and test volume forecasts of leading tumor markers by market segment and country; profiles the dominant players along with potential entrants into the market. A variety of business expansion strategie s for suppliers are identified in the research study as well. Report Scope: Overview of the global tumour diagnostics market, including 5-year test volume and sales projections by country; market segmentation analysis; the estimated number of laboratories performing respective testing (by country); tumour statistics, etiology and latest developments region-wise. Up-close look at the opportunities arising including appropriate strategic recommendations. Thorough study of more than 200 cancer diagnostic tests, current and emerging. Suppliersâ?? shares and market shares (by test and country); 5-year test volume and sales forecast data for key tumour markers (by country and market segment). Comprehensive assessment of instrumentation for cancer testing. Assessment of modern technologies (including complementing/ competing ones) and their potential applications for cancer diagnostic testing; extensive listings of organisations developing novel tumour diagnostic tests and detection technologies. Strategic evaluations of the top suppliers and start-ups that develop new cancer diagnostic products and technologies. More comprehensive and new market research reports by the publisher can be found at VPG page. Contact Information Natalie Aster The Market Publishers, Ltd. http://marketpublishers.com/ +44 2081446009

Posted in Mesothelioma News | Leave a comment